Aspira Pathlab & Diagnostics Ltd
Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services[1]
- Market Cap ₹ 42.6 Cr.
- Current Price ₹ 41.4
- High / Low ₹ 50.1 / 25.0
- Stock P/E
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 18.7%
- Promoter holding has decreased over last 3 years: -17.5%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| 13.20 | |
| 14.75 | |
| Operating Profit | -1.55 |
| OPM % | -11.74% |
| 0.42 | |
| Interest | 0.00 |
| Depreciation | 1.54 |
| Profit before tax | -2.67 |
| Tax % | 0.00% |
| -2.67 | |
| EPS in Rs | -2.59 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -17% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Total Liabilities | |
| CWIP | |
| Investments | |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Sep
-
Notice Convening 51St Annual General Meeting For The Financial Year 2023-24
5 Sep - Notice for 51st Annual General Meeting on September 27, 2024.
- Reg. 34 (1) Annual Report. 5 Sep
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
4 Sep - Newspaper Publication for the intimation of 51st Annual General Meeting of the Company.
-
Book Closure & E-Voting Intimation For The Purpose 51St Annual General Meeting
24 Aug - 51st Annual General Meeting scheduled for September 27, 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company is in the business of running, owning, managing and administering Diagnostics Centers in Mumbai